Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens

Gastroenterology

Volumn 123, Issue 3, 2002, Pages 689-699

  Landers, Carol J ^a   Cohavy, Offer ^a   Misra, Rajeev ^b   Yang, Huiying ^a   Lin, YingChao ^a   Braun, Jonathan ^c   Targan, Stephan R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISACCHAROMYCES CEREVISIAE ANTIBODY; AUTOANTIGEN; BACTERIAL ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NEUTROPHIL CYTOPLASMIC ANTIBODY; OUTER MEMBRANE PROTEIN; PORIN C ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIGEN PURIFICATION; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC ANALYSIS; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MOLECULAR STABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROPREVALENCE;

EID: 0036726184     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.35379     Document Type: Article

References (57)

1. Mucosal immunity and inflammation. II. The yin and yang of T cells in intestinal inflammation: Pathogenic and protective roles in a mouse colitis model
2. The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease
3. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease
4. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats
5. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice
6. IL-10 deficient mice monoassociated with non-pathogenic Enterococcus faecalis develop chronic colitis
7. A novel urease-negative Helicobacter species associated with colitis and typhlitis in IL-10-deficient mice
8. + T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: Increased T helper cell type 1 response and ability to transfer disease
9. Metronidazole plus ciprofloxacin in the treatment of active, refractory Crohn's disease: Results of an open study
10. An antibiotic regimen for the treatment of active Crohn's disease: A randomized, controlled clinical trial of metronidazole plus ciprofloxacin
11. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum
12. Immunoglobulin A (IgA) and IgG serum antibodies to mycobacterial antigens in Crohn's disease patients and their relatives
13. Mycobacterium paratuberculosis DNA in Crohn's disease tissue
14. Polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium subsp silvaticum in long term cultures from Crohn's disease and control tissues
15. Specific detection of Mycobacterium paratuberculosis DNA associated with granulomatous tissue in Crohn's disease
16. Characterization of a specific Mycobacterium paratuberculosis recombinant clone expressing 35, 000-molecular-weight antigen and reactivity with sera from animals with clinical and subclinical Johne's disease
17. Role of Mycobacterium paratuberculosis in Crohn's disease: A prospective, controlled study using polymerase chain reaction
18. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope
19. T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans
20. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease
21. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens
22. Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease (IBD)
23. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
24. Identification of a novel bacterial sequence associated with Crohn's disease
25. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup
26. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease
27. Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease
28. Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis
29. Definition of ocular antigens in ciliary body and retinal ganglion cells by the marker antibody pANCA
30. Mast cell and neuroendocrine cytoplasmic autoantigen(s) detected by monoclonal pANCA antibodies
31. Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA
32. Selected, not global, loss of tolerance using Crohn's disease (CD)-associated immune responses to auto-and specific bacterial antigens
33. Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: Is IgA antibody a marker for Crohn's disease?
34. Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease
35. Specific antibody response to oligomannosidic epitopes in Crohn's disease
36. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease
37. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role
38. IgA serum antibody reactivity with 12, a novel Crohn's disease marker: Anti-I2 level is independent from ASCA and ANCA levels even though IgA ASCA positivity is correlated with anti-I2 positivity
39. The Crohn's disease lesion derived gene I2 encodes the core peptide of a transcriptional regulator of Pseudomonas fluorescens in the functional domain of a novel T cell superantigen
40. Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitis
41. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis
42. A distinct subset of antineutrophi(cytoplasmic antibodies is associated with inflammatory bowel disease
43. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: Ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis
44. Eukaryotic proteins expressed in Escherichia coli: An improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase
45. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics
46. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouchanal anastomosis
47. Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens
48. Bacteria-specific T-cell clones are selective in their reactivity towards different enterobacteria or H. pylori and increased in inflammatory bowel disease
49. Specific seroreactivity of Crohn's disease patients against p35 and p36 antigens of M. avium subsp. paratuberculosis
50. Is measles infection associated with Crohn's disease?
51. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria
52. Antibody (IgG, IgA, and IgM) to baker's yeast (Saccharomyces cerevisiae), yeast mannan, gliadin, ovalbumin and betalactoglobulin in monozygotic twins with inflammatory bowel disease
53. Responses to self and non-self intestinal microflora in health and inflammatory bowel disease
54. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12
55. Memory/effector T cells in TCR transgenic mice develop via recognition of enteric antigens by a second, endogenous TCR